CHAPTER 19. DRUGS: INDIANA LEGEND DRUG ACT
IC 16-42-19
Chapter 19. Drugs: Indiana Legend Drug Act
IC 16-42-19-1
Intent of chapter
Sec. 1. This chapter is intended to supplement IC 16-42-1 through
IC 16-42-4.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-2
"Drug" defined
Sec. 2. As used in this chapter, "drug" means the following:
(1) Articles or substances recognized in United States
Pharmacopeial Convention, Inc.; The United States
Pharmacopeia, Twenty-Second Edition (1990) or United States
Pharmacopeial Convention, Inc.; The National Formulary,
Seventeenth Edition (1990) as revised by United States
Pharmacopeial Convention, Inc.; Supplement 1 to The United
States Pharmacopeia, Twenty-Second Edition and The National
Formulary, Seventeenth Edition (1990); and any supplements
printed after 1990.
(2) Articles or substances intended for use in the diagnosis,
cure, mitigation, treatment, or prevention of disease in human
beings or other animals.
(3) Articles other than food intended to affect the structure or
any function of the body of human beings or other animals.
(4) Articles intended for use as a component of any article
specified in subdivision (1), (2), or (3).
(5) Devices.
As added by P.L.2-1993, SEC.25. Amended by P.L.239-1999, SEC.1.
IC 16-42-19-3
"Drug order" defined
Sec. 3. As used in this chapter, "drug order" means an order that
meets the following conditions:
(1) Is:
(A) a written order in a hospital or other health care
institution for an ultimate user for a drug or device, issued
and signed by a practitioner; or
(B) an order transmitted by other means of communication
from a practitioner that is immediately reduced to writing by
the pharmacist, registered nurse, or other licensed health
care practitioner authorized by the hospital or institution.
(2) Contains the following:
(A) The name and bed number of the patient.
(B) The name and strength or size of the drug or device.
(C) Unless specified by individual institutional policy or
guidelines, the amount to be dispensed either in quantity or
days.
(D) Adequate directions for the proper use of the drug or
device when administered to the patient.
(E) The name of the prescriber.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-4
"Investigational or new drug" defined
Sec. 4. As used in this chapter, "investigational or new drug"
means a drug that is limited by state law to use under professional
supervision of a practitioner authorized by law to prescribe or
administer the drug.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-5
"Practitioner" defined
Sec. 5. As used in this chapter, "practitioner" means any of the
following:
(1) A physician licensed under IC 25-22.5.
(2) A veterinarian licensed to practice veterinary medicine in
Indiana.
(3) A dentist licensed to practice dentistry in Indiana.
(4) A podiatrist licensed to practice podiatric medicine in
Indiana.
(5) An optometrist who is:
(A) licensed to practice optometry in Indiana; and
(B) certified under IC 25-24-3.
(6) An advanced practice nurse who meets the requirements of
IC 25-23-1-19.5.
(7) A physician assistant licensed under IC 25-27.5 who is
delegated prescriptive authority under IC 25-27.5-5-6.
As added by P.L.2-1993, SEC.25. Amended by P.L.185-1993, SEC.1;
P.L.157-2006, SEC.6; P.L.90-2007, SEC.2; P.L.177-2009, SEC.8.
IC 16-42-19-6
"Precursor" defined
Sec. 6. As used in this chapter, "precursor" means a substance,
other than a legend drug, that:
(1) is an immediate chemical intermediate that can be processed
or synthesized into a legend drug; and
(2) is used or produced primarily for use in the manufacture of
a legend drug by persons other than persons:
(A) licensed to manufacture the legend drug by the Indiana
board of pharmacy;
(B) registered by the state department; or
(C) licensed to practice pharmacy by the Indiana board of
pharmacy.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-7
"Prescription" defined
Sec. 7. As used in this chapter, "prescription" means:
(1) a written order to or for an ultimate user for a drug or device
containing the name and address of the patient, the name and
strength or size of the drug or device, the amount to be
dispensed, adequate directions for the proper use of the drug or
device by the patient, and the name of the practitioner, issued
and signed by a practitioner; or
(2) an order transmitted by other means of communication from
a practitioner that is:
(A) immediately reduced to writing by the pharmacist or
pharmacist intern (as defined in IC 25-26-13-2); or
(B) for an electronically transmitted prescription:
(i) has the electronic signature of the practitioner; and
(ii) is recorded by the pharmacist in an electronic format.
As added by P.L.2-1993, SEC.25. Amended by P.L.204-2005, SEC.6.
IC 16-42-19-8
"Sale" defined
Sec. 8. As used in this chapter, "sale" means every sale and
includes the following:
(1) Manufacturing, processing, transporting, handling, packing,
or any other production, preparation, or repackaging.
(2) Exposure, offer, or any other proffer.
(3) Holding, storing, or any other possession.
(4) Dispensing, giving, delivering, or any other supplying.
(5) Applying, administering, or any other using.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-9
"Warehouseman" defined
Sec. 9. As used in this chapter, "warehouseman" means a person
who stores legend drugs for others and who has no control over the
disposition of legend drugs except for the purpose of storage.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-10
"Wholesaler" defined
Sec. 10. As used in this chapter, "wholesaler" means a person
engaged in the business of distributing legend drugs that the person
has not produced or prepared to persons included in any of the
classes named in section 21 of this chapter.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-11
Sale of legend drug unlawful; exceptions
Sec. 11. (a) Except as provided in section 21 of this chapter, a
person may not sell a legend drug unless either of the following
conditions exist:
(1) Except as provided in subsection (b), the legend drug is
dispensed by a pharmacist upon an original prescription or drug
order with the drug product specified on the prescription or
drug order or by the authorization of the practitioner and there
is affixed to the immediate container in which the drug is
delivered a label bearing the following:
(A) The name, address, and phone number of the
establishment from which the drug was dispensed.
(B) The date on which the prescription for the drug was
filled.
(C) The number of the prescription as filed in the
prescription files of the pharmacist who filled the
prescription.
(D) The name of the practitioner who prescribed the drug.
(E) The name of the patient, or if the drug was prescribed for
an animal, a statement of the species of the animal.
(F) The directions for the use of the drug as contained in the
prescription.
(2) The legend drug is delivered by the practitioner in good
faith in the course of practice and the immediate container in
which the drug is delivered bears a label on which appears the
following:
(A) The directions for use of the drug.
(B) The name and address of the practitioner.
(C) The name of the patient.
(D) If the drug is prescribed for an animal, a statement of the
species of the animal.
This section does not prohibit a practitioner from delivering
professional samples of legend drugs in their original containers in
the course of the practitioner's practice when oral directions for use
are given at the time of delivery.
(b) Notwithstanding subsection (a)(1), the following apply:
(1) A pharmacist at a hospital licensed under IC 16-21 may fill
a drug order for a legend drug with a drug product allowed
under the hospital's policies and procedures for the use,
selection, and procurement of drugs.
(2) A pharmacist who fills a prescription for a legend drug must
comply with IC 16-42-22 and IC 25-26-16.
As added by P.L.2-1993, SEC.25. Amended by P.L.239-1999, SEC.2.
IC 16-42-19-12
Refilling prescription or drug order
Sec. 12. Except as authorized under IC 25-26-13-25(d), a person
may not refill a prescription or drug order for a legend drug except
in the manner designated on the prescription or drug order or by the
authorization of the practitioner.
As added by P.L.2-1993, SEC.25. Amended by P.L.270-2001, SEC.1;
P.L.204-2005, SEC.7.
IC 16-42-19-13
Possession or use of legend drug or precursor
Sec. 13. A person may not possess or use a legend drug or a
precursor unless the person obtains the drug:
(1) on the prescription or drug order of a practitioner; or
(2) in accordance with section 11(2) or 21 of this chapter.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-14
Records
Sec. 14. A person may not fail to keep records as required by
section 22 of this chapter.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-15
Inspection of records
Sec. 15. A person may not refuse to make available and to accord
full opportunity to check a record, as required by section 22 of this
chapter.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-16
Unlawful acts
Sec. 16. A person may not do any of the following:
(1) Obtain or attempt to obtain a legend drug or procure or
attempt to procure the administration of a legend drug by any of
the following:
(A) Fraud, deceit, misrepresentation, or subterfuge.
(B) The forgery or alteration of a prescription, drug order, or
written order.
(C) The concealment of a material fact.
(D) The use of a false name or the giving of a false address.
(2) Communicate information to a physician in an effort
unlawfully to procure a legend drug or unlawfully to procure
the administration of a legend drug. Such a communication is
not considered a privileged communication.
(3) Intentionally make a false statement in a prescription, drug
order, order, report, or record required by this chapter.
(4) For the purpose of obtaining a legend drug, falsely assume
the title of or represent oneself to be a manufacturer,
wholesaler, pharmacist, physician, dentist, veterinarian, or other
person.
(5) Make or utter a false or forged prescription or false drug
order or forged written order.
(6) Affix a false or forged label to a package or receptacle
containing legend drugs. This subdivision does not apply to law
enforcement agencies or their representatives while engaged in
enforcing this chapter.
(7) Dispense a legend drug except as provided in this chapter.
As added by P.L.2-1993, SEC.25. Amended by P.L.239-1999, SEC.3.
IC 16-42-19-17
Legend drug smoking devices
Sec. 17. A person may not possess or have under the person's
control with intent to violate this chapter an instrument or
contrivance designed or generally used in smoking a legend drug.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-18
Legend drug injection devices
Sec. 18. A person may not possess or have under control with
intent to violate this chapter a hypodermic syringe or needle or an
instrument adapted for the use of a legend drug by injection in a
human being.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-19
Anabolic steroids
Sec. 19. Except as provided in section 21 of this chapter, a person
may not possess or use an anabolic steroid without a valid
prescription or drug order issued by a practitioner acting in the usual
course of the practitioner's professional practice.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-20
Validity of prescriptions or drug orders
Sec. 20. (a) A prescription or drug order for a legend drug is not
valid unless the prescription or drug order is issued for a legitimate
medical purpose by a practitioner acting in the usual course of the
practitioner's business.
(b) A practitioner may not knowingly issue an invalid prescription
or drug order for a legend drug.
(c) A pharmacist may not knowingly fill an invalid prescription
or drug order for a legend drug.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-21
Authorized sale or possession
Sec. 21. Sections 11, 13, 19, and 25(b) of this chapter are not
applicable to the following:
(1) The sale of legend drugs to persons included in any of the
classes named in subdivision (2), or to the agents or employees
of such persons for use in the usual course of their business or
practice or in the performance of their official duties.
(2) Possession of legend drugs by the following persons or their
agents or employees for such use:
(A) Pharmacists.
(B) Practitioners.
(C) Persons who procure legend drugs for handling by or
under the supervision of pharmacists or practitioners
employed by them or for the purpose of lawful research,
teaching, or testing and not for resale.
(D) Hospitals and other institutions that procure legend
drugs for lawful administration by practitioners.
(E) Manufacturers and wholesalers.
(F) Carriers and warehousemen.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-22
Manufacturers and wholesalers; records
Sec. 22. (a) Manufacturers and wholesalers shall maintain records
of the movement in commerce of legend drugs for two (2) years
immediately following the date of the last entry on those records and
shall make those records available, at reasonable times, to law
enforcement agencies and their representatives in the enforcement of
this chapter.
(b) Evidence obtained under this section may not be used in a
criminal prosecution of the person from whom obtained.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-23
Mechanical device for storage or dispensing of drugs; restrictions;
inspection of premises
Sec. 23. (a) As used in this section, "mechanical device" means a
machine for storage and dispensing of drugs. The term does not
include devices or instruments used by practitioners in the diagnosis,
cure, mitigation, treatment, or prevention of disease in human beings
or other animals.
(b) A person may not maintain, operate, or use any type of
mechanical device in which any legend drug or narcotic drug is
stored or held for the purpose of dispensing the drug from the
mechanical device. However, the mechanical device may be used for
the storage and dispensing of legend drugs if:
(1) the mechanical device is used in a:
(A) pharmacy that holds a permit issued by the Indiana
board of pharmacy;
(B) remote location under the jurisdiction of the board of
pharmacy; or
(C) health care facility that is licensed under IC 16-28 or
IC 16-21-2; and
(2) the mechanical device is operated under the direct
supervision and control of a:
(A) registered pharmacist; or
(B) practitioner;
who is directly responsible for dispensing the drug from the
mechanical device.
(c) Inspectors of the Indiana board of pharmacy may inspect the
premises of any person suspected of violating this section.
As added by P.L.2-1993, SEC.25. Amended by P.L.98-2006, SEC.1.
IC 16-42-19-24
Nuisance; place of illegal use or storage; prohibited acts
Sec. 24. (a) A store, shop, warehouse, dwelling house, apartment,
building, vehicle, boat, aircraft, or any other place that is used:
(1) by a person for the purpose of unlawfully using a legend
drug; or
(2) for the unlawful keeping or selling of the legend drug;
is a common nuisance.
(b) A person may not:
(1) keep or maintain a common nuisance; or
(2) frequent or visit a place knowing the place to be used for a
purpose;
as described in subsection (a).
As added by P.L.2-1993, SEC.25.
IC 16-42-19-25
Anabolic steroids; unlawful acts
Sec. 25. (a) A practitioner may not prescribe, order, distribute,
supply, or sell an anabolic steroid for any of the following:
(1) Enhancing performance in an exercise, sport, or game.
(2) Hormonal manipulation intended to increase muscle mass,
strength, or weight without a medical necessity.
(b) Except as provided in section 21 of this chapter, a person who
is not a practitioner or lawful manufacturer of anabolic steroids may
not do any of the following:
(1) Knowingly or intentionally manufacture or deliver an
anabolic steroid, pure or adulterated.
(2) Possess, with intent to manufacture or deliver, an anabolic
steroid.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-26
Pleading
Sec. 26. In:
(1) any complaint, information, affidavit, or indictment; and
(2) any action or proceeding brought for the enforcement of any
provision of this chapter;
it is not necessary to negate an exception, excuse, proviso, or
exemption contained in this chapter. The burden of proof of such an
exception, excuse, proviso, or exemption is upon the defendant.
As added by P.L.2-1993, SEC.25.
IC 16-42-19-27
Violations; prior offenders; anabolic steroids
Sec. 27. (a) A person who knowingly violates this chapter, except
sections 24 and 25(b) of this chapter, commits a Class D felony.
However, the offense is a Class C felony if the person has a prior
conviction under this subsection or IC 16-6-8-10(a) before its repeal.
(b) A person who violates section 24 of this chapter commits a
Class B misdemeanor.
(c) A person who violates section 25(b) of this chapter commits
dealing in an anabolic steroid, a Class C felony. However, the
offense is a Class B felony if the person delivered the anabolic
steroid to a person who is:
(1) less than eighteen (18) years of age; and
(2) at least three (3) years younger than the delivering person.
As added by P.L.2-1993, SEC.25. Amended by P.L.2-2005, SEC.58.
IC 16-42-19-28
Immunity of law enforcement officers from prosecution
Sec. 28. Law enforcement officers in the performance of their
official duties are exempt from prosecution for and may not be
convicted of violations of this chapter.
As added by P.L.2-1993, SEC.25.